Gene · 8243
Papers2,883
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,883
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Opportunities of Disrupting Genome Integrity in Adult Diffuse Glioma. | Biomedicines | 2022 | 35203541 | PubTator, text mining | PubMed |
| HiCAR is a robust and sensitive method to analyze open-chromatin-associated genome organization. | Mol Cell | 2022 | 35196517 | PubTator, text mining | PubMed |
| Diagnostic yield of next-generation sequencing in 87 families with neurodevelopmental disorders. | Orphanet J Rare Dis | 2022 | 35183220 | PubTator, text mining | PubMed |
| EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells. | Mol Cell | 2022 | 35182476 | PubTator, text mining | PubMed |
| Transcription factor protein interactomes reveal genetic determinants in heart disease. | Cell | 2022 | 35182466 | PubTator, text mining | PubMed |
| Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. | Am J Hematol | 2022 | 35180323 | PubTator, text mining | PubMed |
| Enhancer RNA: What we know and what we can achieve. | Cell Prolif | 2022 | 35170113 | PubTator, text mining | PubMed |
| The role of chromatin loop extrusion in antibody diversification. | Nat Rev Immunol | 2022 | 35169260 | PubTator, text mining | PubMed |
| LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint. | Proc Natl Acad Sci U S A | 2022 | 35169076 | PubTator, text mining | PubMed |
| Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms. | Front Immunol | 2022 | 35154108 | PubTator, text mining | PubMed |
| Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1. | Proc Natl Acad Sci U S A | 2022 | 35149558 | PubTator, text mining | PubMed |
| Case Report: Biallelic Loss of Function ATM due to Pathogenic Synonymous and Novel Deep Intronic Variant c.1803-270T > G Identified by Genome Sequencing in a Child With Ataxia-Telangiectasia. | Front Genet | 2022 | 35145552 | PubTator, text mining | PubMed |
| GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. | Nat Genet | 2022 | 35145301 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Hypertrophic pyloric stenosis masked by kidney failure in a male infant with a contiguous gene deletion syndrome at Xp22.31 involving the steroid sulfatase gene: case report. | Ital J Pediatr | 2022 | 35115028 | PubTator, text mining | PubMed |
| Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours. | EMBO Mol Med | 2022 | 35107878 | PubTator, text mining | PubMed |
| A knowledge graph to interpret clinical proteomics data. | Nat Biotechnol | 2022 | 35102292 | PubTator, text mining | PubMed |
| Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms. | Leukemia | 2022 | 35091658 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8243/papers?page=32